MDXG earnings date and last-quarter result: next report 2026-07-29, last quarter beat, P/E 20.33. Updated 2026-07-23.
MiMedx Group (MDXG) Research Hub
MiMedx Group (MDXG) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 3.85 USD (-1.53%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 20.33, market cap 0.62B. This hub links to the full technical, earnings and options research available for MDXG.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 3.85 USD (-1.53%) |
| 52-week range | 3.58 USD – 4.99 USD |
| Trend regime | Range |
| 14-day RSI | 26.1 (Oversold) |
| Trailing P/E | 20.33 |
| Market cap | 0.62B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-29 |
Available research for MDXG
Covered Call on MDXG: how it works, illustrative setup around the real 3.85 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on MDXG: how it works, illustrative setup around the real 3.85 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on MDXG: how it works, illustrative setup around the real 3.85 USD price, max profit/loss, breakeven and when to use it. Educational.
MDXG technical analysis: range, last 3.85 USD, RSI 26.1, 52w range 3.58 USD–4.99 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is MDXG in?
MiMedx Group (MDXG) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is MDXG in an uptrend or downtrend?
As of 2026-10-26, MDXG is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is MDXG's trailing P/E ratio?
MDXG's trailing P/E is 20.33, with a market cap of 0.62B. See the earnings research page for full valuation detail.
When does MDXG next report earnings?
MDXG is next scheduled to report earnings on 2026-07-29.